Inclusion of ACKR5 in the Systematic Nomenclature of Atypical Chemokine Receptors
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Comerford I, McColl S
. Atypical chemokine receptors in the immune system. Nat Rev Immunol. 2024; 24(10):753-769.
DOI: 10.1038/s41577-024-01025-5.
View
2.
Bachelerie F, Ben-Baruch A, Burkhardt A, Combadiere C, Farber J, Graham G
. International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev. 2013; 66(1):1-79.
PMC: 3880466.
DOI: 10.1124/pr.113.007724.
View
3.
Chevigne A, Legler D, Rot A, Sozzani S, Szpakowska M, Thelen M
. International Union of Basic and Clinical Pharmacology. CXVIII. Update on the nomenclature for atypical chemokine receptors, including ACKR5. Pharmacol Rev. 2025; 77(1):100012.
DOI: 10.1124/pharmrev.124.001361.
View
4.
Le Mercier A, Bonnavion R, Yu W, Alnouri M, Ramas S, Zhang Y
. GPR182 is an endothelium-specific atypical chemokine receptor that maintains hematopoietic stem cell homeostasis. Proc Natl Acad Sci U S A. 2021; 118(17).
PMC: 8092405.
DOI: 10.1073/pnas.2021596118.
View
5.
Torphy R, Sun Y, Lin R, Caffrey-Carr A, Fujiwara Y, Ho F
. GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models. Nat Commun. 2022; 13(1):97.
PMC: 8748779.
DOI: 10.1038/s41467-021-27658-x.
View